Esma Updates Derivatives Reporting Guidance

Esma
Esma is responsible for the technical implementation of regulation such as Emir and Mifid.

Specifically, Esma is providing an update for how it expects exchange-traded derivatives (ETD) to be reported under European Market Infrastructure Regulation (Emir) and Markets in Financial Instrument Directive (Mifid) mandates.

Emir will require all ETD transactions, regardless of whether they are on or off exchange, to be reported to a trade repository from February 12, 2014. As the conclusion of a contract counts as execution under Mifid, any entity completing an ETD transaction will be covered by the requirements, which will include central counterparty clearing houses (CCPs) clearing the trade, clearing members doing the same, investment firms executing on a venue as a member, and counterparties to contracts that encompass all other bodies. Certain exemptions exist, such as a bracket of non-financial firms.

Other areas covered by the update include segregation and portability questions related to CCPs, backloading as it relates to outstanding position reporting after Emir's entry into force, a table of fields for reporting to trade repositories, position-level reporting, collateral codes, and a host of technical information related to ETD reporting.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here